Figure 8From: A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureusBacterial outgrowth during postinfluenza pneumonia. (* P < 0.05). S. aureus titration was performed on day 2 after infection with S. aureus. The S. aureus titer in mice vaccinated with pEGFP/Ag85A-HA2 was lower than that in mice vaccinated with pEGFP/HA2.Back to article page